Welch Group, LLC Gilead Sciences, Inc. Transaction History

Welch Group, LLC

$2.29 Billion
Q3 2024

A detailed history of Welch Group, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Welch Group, LLC holds 4,136 shares of GILD stock, worth $382,083. This represents 0.02% of its overall portfolio holdings.

Number of Shares

4,136

Previous 4,136 -0.0%

Holding current value

$382,083

Previous $283,000 22.26%

% of portfolio

0.02%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 09, 2024	BUY	$71.58 - $87.29 $60,413 - $73,672	844 Added 25.64%	4,136 $302,000
Q3 2023 Oct 18, 2023	SELL	$73.94 - $80.67 $3,918 - $4,275	-53 Reduced 1.58%	3,292 $246,000
Q2 2023 Jul 18, 2023	SELL	$76.01 - $86.7 $24,171 - $27,570	-318 Reduced 8.68%	3,345 $257,000
Q1 2023 Apr 13, 2023	SELL	$77.31 - $88.08 $1,314 - $1,497	-17 Reduced 0.46%	3,663 $303,000
Q4 2022 Jan 27, 2023	SELL	$62.32 - $89.47 $20,939 - $30,061	-336 Reduced 8.37%	3,680 $315,000
Q3 2022 Oct 13, 2022	BUY	$59.54 - $68.01 $20,005 - $22,851	336 Added 9.13%	4,016 $248,000
Q1 2022 Apr 29, 2022	BUY	$57.92 - $72.58 $38,922 - $48,773	672 Added 22.34%	3,680 $219,000
Q4 2021 Jan 26, 2022	BUY	$64.88 - $73.64 $195,159 - $221,509	3,008 New	3,008 $218,000
Q3 2020 Oct 28, 2020	SELL	$62.1 - $78.08 $171,644 - $215,813	-2,764 Closed	0 $0
Q2 2020 Jul 22, 2020	BUY	$72.34 - $84.0 $78,633 - $91,308	1,087 Added 64.82%	2,764 $213,000
Q1 2020 Apr 28, 2020	SELL	$62.63 - $80.22 $256,031 - $327,939	-4,088 Reduced 70.91%	1,677 $125,000
Q4 2019 Jan 24, 2020	BUY	$61.62 - $67.78 $36,047 - $39,651	585 Added 11.29%	5,765 $375,000
Q3 2019 Nov 05, 2019	BUY	$62.51 - $69.0 $2,375 - $2,622	38 Added 0.74%	5,180 $328,000
Q2 2019 Jul 11, 2019	SELL	$61.87 - $69.38 $216,421 - $242,691	-3,498 Reduced 40.49%	5,142 $347,000
Q1 2019 Apr 15, 2019	BUY	$62.53 - $70.05 $53,338 - $59,752	853 Added 10.95%	8,640 $562,000
Q4 2018 Jan 10, 2019	BUY	$60.54 - $79.0 $65,262 - $85,162	1,078 Added 16.07%	7,787 $487,000
Q3 2018 Nov 01, 2018	BUY	$71.28 - $78.92 $48,826 - $54,060	685 Added 11.37%	6,709 $518,000
Q2 2018 Jul 30, 2018	BUY	$64.88 - $75.68 $29,650 - $34,585	457 Added 8.21%	6,024 $427,000
Q1 2018 Apr 23, 2018	BUY	$72.84 - $88.8 $133,952 - $163,303	1,839 Added 49.33%	5,567 $420,000
Q4 2017 Feb 01, 2018	BUY	$71.15 - $83.52 $18,427 - $21,631	259 Added 7.47%	3,728 $267,000
Q3 2017 Nov 07, 2017	SELL	$72.11 - $85.47 $64,682 - $76,666	-897 Reduced 20.55%	3,469 $281,000
Q2 2017 Aug 07, 2017	BUY	N/A	4,366	4,366 $309,000

Others Institutions Holding GILD

# of Institutions

1,925

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Welch Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Welch Group, LLC with notifications on news.

Account